NGM Biopharmaceuticals (NGM) PT Lowered to $22 at Stifel, Keeps 'Buy'
Tweet Send to a Friend
Stifel analyst Derek Archila lowered the price target on NGM Biopharmaceuticals (NASDAQ: NGM) to $22.00 (from $43.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
